These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 3154465

  • 21. Sequential antilymphocyte globulin cyclosporine therapy in cadaver renal transplantation.
    Sollinger HW, Deierhoi M, Kalayoglu M, Belzer FO.
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):16-8. PubMed ID: 3515685
    [No Abstract] [Full Text] [Related]

  • 22. The case against conversion to azathioprine in cyclosporine-treated renal recipients.
    Flechner SM, Lorber M, Van Buren C, Kerman R, Kahan BD.
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):276-81. PubMed ID: 3895667
    [No Abstract] [Full Text] [Related]

  • 23. Monitoring of cyclosporine by serial posttransplant pharmacokinetic studies in renal transplant patients.
    Awni WM, Heim-Duthoy K, Kasiske BL.
    Transplant Proc; 1990 Jun; 22(3):1343-4. PubMed ID: 2349693
    [No Abstract] [Full Text] [Related]

  • 24. Triple therapy with low-dose cyclosporine, azathioprine, and steroids: long-term results of a randomized study in cadaver donor renal transplantation.
    Fries D, Hiesse C, Santelli G, Gardin JP, Cantarovich M, Lantz O, Charpentier B, Paillard M, Benoit G.
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):130-5. PubMed ID: 3291226
    [No Abstract] [Full Text] [Related]

  • 25. Comparison of kidney transplant survival between patients treated with cyclosporine and those treated with azathioprine and antithymocyte globulin.
    Cho SI, Bradley JW, Monaco AP, Tilney NL.
    Am J Surg; 1984 Apr; 147(4):518-23. PubMed ID: 6370008
    [Abstract] [Full Text] [Related]

  • 26. Optimal results in cadaver-donor renal transplantation using prophylactic ALG, cyclosporine, and prednisone.
    Hiesse C, Fries D, Charpentier B, Neyrat N, Rieu P, Cantarovich M, Lantz O, Bellamy J, Benoit G.
    Transplant Proc; 1987 Oct; 19(5):3670-1. PubMed ID: 3313885
    [No Abstract] [Full Text] [Related]

  • 27. Cadaveric renal transplant without prophylactic prednisone therapy.
    Bry W, Warvariv V, Bohannon L, Feduska N, Straube B, Collins G, Levin B.
    Transplant Proc; 1991 Feb; 23(1 Pt 2):994-6. PubMed ID: 1989357
    [No Abstract] [Full Text] [Related]

  • 28. A comparison of two cyclosporine protocols at the University of Minnesota.
    Fryd DS, Canafax DM, Matas AJ, Dunn D, Payne WD, Sutherland DE, Najarian JS.
    Clin Transpl; 1988 Feb; ():79-90. PubMed ID: 3154498
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. New immunosuppressive drug combinations for mismatched related and cadaveric renal transplantation.
    Simmons RL, Canafax DM, Fryd DS, Ascher NL, Payne WD, Sutherland DE, Najarian JS.
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):76-81. PubMed ID: 3008390
    [No Abstract] [Full Text] [Related]

  • 32. Single center experience of the effect of delayed function on outcome in retransplant recipients of cadaveric renal allografts.
    Langley J, Vergne-Marini P, Dickerman RM, Brinker KR, Land G.
    Transplant Proc; 1991 Apr; 23(2):1757-9. PubMed ID: 2053145
    [Abstract] [Full Text] [Related]

  • 33. Comparison of antithymocyte globulin antirejection treatment in renal transplant patients with either cyclosporine or azathioprine as basic immunosuppression.
    Hoitsma AJ, Wetzels JF, Berden JH, Koene RA.
    Transplant Proc; 1987 Oct; 19(5):3589-91. PubMed ID: 3313864
    [No Abstract] [Full Text] [Related]

  • 34. Effect of sequential Minnesota-antilymphocyte globulin and cyclosporine therapy in primary cadaveric renal transplant recipients with delayed graft function.
    Venkat KK, Kupin W, Oh HK.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1544-5. PubMed ID: 2652499
    [No Abstract] [Full Text] [Related]

  • 35. Single-center analysis of 468 first cadaveric kidney allografts with a uniform ATG-CsA sequential therapy.
    Giral M, Taddei C, Nguyen JM, Dantal J, Hourmant M, Cantarovich D, Blancho G, Ancelet D, Soulillou JP.
    Clin Transpl; 1996 Feb; ():257-64. PubMed ID: 9286575
    [Abstract] [Full Text] [Related]

  • 36. [Immunosuppression in organ transplantation (author's transl)].
    Montandon A.
    Ther Umsch; 1979 May; 36(5):418-25. PubMed ID: 88084
    [No Abstract] [Full Text] [Related]

  • 37. Sequential biological immunosuppression. Induction therapy with rabbit antithymocyte globulin.
    Guttmann RD, Flemming C.
    Clin Transplant; 1997 Jun; 11(3):185-92. PubMed ID: 9193840
    [Abstract] [Full Text] [Related]

  • 38. Experience with cyclosporine and prednisone as immunosuppressants in 36 renal transplants.
    Kovithavongs T, Boake R, Lakey WH, Ulan RA, Dossetor JB.
    Transplant Proc; 1984 Aug; 16(4):1083-5. PubMed ID: 6380055
    [No Abstract] [Full Text] [Related]

  • 39. [Spontaneous kidney transplant rupture--effect of immunosuppressive therapy on incidence of rupture].
    Oesterwitz H, Strobelt V, May G, Horlbeck R.
    Z Urol Nephrol; 1990 Apr; 83(4):157-63. PubMed ID: 2378176
    [Abstract] [Full Text] [Related]

  • 40. Two immunosuppressive drug regimens after renal transplantation: low dosage of cyclosporine adjusted on the basis of high-performance liquid chromatography whole blood levels and prednisone.
    Uchida K, Orihara A, Yamada N, Tominaga Y, Kawai M, Tanaka Y, Morozumi K, Hayashi S, Satake M, Taira N.
    Transplant Proc; 1988 Feb; 20(1 Suppl 1):401-5. PubMed ID: 3279629
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.